about
Insulin sensitivity and complications in type 1 diabetes: New insightsEarly diabetic nephropathy in type 1 diabetes: new insightsAchieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetesInsulin sensitivity is an important determinant of renal health in adolescents with type 2 diabetes.Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes.Estimated insulin sensitivity predicts regression of albuminuria in Type 1 diabetes.Association of apolipoprotein B, LDL-C and vascular stiffness in adolescents with type 1 diabetes.Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.Diabetes Complications in Childhood Diabetes-New Biomarkers and Technologies.Measuring glomerular filtration rate by iohexol clearance on filter paper is feasible in adolescents with type 1 diabetes in the ambulatory settingHyperfiltration and uricosuria in adolescents with type 1 diabetes.Fructose and uric acid in diabetic nephropathyCardiopulmonary Dysfunction and Adiponectin in Adolescents With Type 2 DiabetesAge-related consequences of childhood obesity.Risks and benefits of statin use in young people with type 1 diabetes.Fat storage syndrome in Pacific peoples: a combination of environment and genetics?Update on Estimation of Kidney Function in Diabetic Kidney Disease.Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.New and old agents in the management of diabetic nephropathy.Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) SAdiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.Achieving ADA/ISPAD clinical guideline goals is associated with higher insulin sensitivity and cardiopulmonary fitness in adolescents with type 1 diabetes: Results from RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) and Effects of MLeptin is associated with cardiopulmonary fitness independent of body-mass index and insulin sensitivity in adolescents with type 1 diabetes: a brief report from the EMERALD study.Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.Albuminuria is associated with greater copeptin concentrations in men with type 1 diabetes: A brief report from the T1D exchange Biobank.Role of bicarbonate supplementation on urine uric acid crystals and diabetic tubulopathy in adults with type 1 diabetes.Fat Mass Is Associated With Cystatin C and Estimated Glomerular Filtration Rate in Adolescents With Type 1 Diabetes.Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 DiabetesThe Relationships between Markers of Tubular Injury and Intrarenal Hemodynamic Function in Adults with and without Type 1 Diabetes: Results from the Canadian Study of Longevity in Type 1 DiabetesAcute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 DiabetesSerum uromodulin inversely associates with aortic stiffness in youth with type 1 diabetes: A brief report from EMERALD studyRetinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 DiabetesCopeptin and Estimated Insulin Sensitivity in Adults With and Without Type 1 Diabetes: The CACTI StudyPlasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 DiabetesInsulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal FunctionEffect of Surgical Versus Medical Therapy on Diabetic Kidney Disease Over 5 Years in Severely Obese Adolescents With Type 2 DiabetesAssociation between uric acid, renal haemodynamics and arterial stiffness over the natural history of type 1 diabetesSodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?
P50
Q27000205-0B08C07A-20D1-4B28-A98F-4AD44507FB41Q27021632-D5117C9B-0F9A-4F94-9BC7-15D709BB5F6AQ33664505-8F772D9A-5B93-41EB-B2F7-C47F9E6CD7B0Q34392364-FF0466F2-F9CD-42B1-83FC-A701E6F644C9Q34762311-CBC69405-1354-4A5A-978A-B534061E6BDFQ34995698-242B3900-D146-4EE6-AEA8-A96ED7945AF6Q35667553-02C86C41-5E39-4169-B175-58B9FC2A65F7Q35876203-DF50D96D-402F-4C08-AADE-F188FC16FBE2Q35943762-E7888CEF-C959-48F2-8C07-FA344B2E2D6AQ36095944-967116E7-D99E-4AB7-9A90-D546E09A0A26Q36276008-B0A06D97-F549-479D-9C1A-E421B29DFAA0Q36730536-B9A7529D-183A-4DC0-B53C-9B13C1C63247Q36782938-B4F8EB6D-9307-4157-A395-BBE005E5EE65Q37090768-3BE66980-BAA7-4493-B1D3-107E30B69255Q38179234-4FB4C49E-29AF-494D-A6EC-A6CA2BAC3FF9Q38209424-B49BAD53-71C2-4B49-A94B-C92E9ABBC559Q38451644-CDE1EF18-0816-4E2C-8483-BC7DC4AE46DDQ38549960-FB42FEA6-BA37-4B84-AD2B-339424190182Q38666896-ACAD3429-D180-44C8-9B25-B91EBF654D49Q38709338-0CAA542E-F647-45F4-BBEC-1580E9EA0D9CQ38738871-E7B43849-8FFD-47D4-8B59-5BCB0E7F0304Q39805797-33C2DD33-A490-4F3B-A615-FD79FB39F44BQ40671262-079D935D-B81F-4129-B639-867398F79E48Q47725249-AF37391A-F239-4A22-8B9C-13DA11589126Q47936691-6FDAC974-B52D-46DC-BC10-EB55E80B3CEFQ50043741-475470AB-D913-4591-AEEE-7574BB6A9B3AQ50300651-AE13C667-5AC7-4ACF-B072-CBA4DA8BEB96Q51246156-58B35166-5BEA-4C70-886B-541A6FB1EEE2Q55036313-43A61308-1C5F-46D6-8294-5DD57770DA73Q57054479-99622BBF-2A1E-4A63-BD45-5089B8BA1D7EQ57470798-1A192711-46D9-4104-B45B-FE68D2B23286Q89239968-D0525907-9482-46E8-A5C7-BF28279581EFQ90023810-B36ED3B3-432C-4869-953A-E67798593AD4Q90316001-6F52BB82-EEFA-4682-87E4-EDF9BB04E00AQ90347485-C564C1B9-BEF2-4991-BD73-5CF90365D844Q90465947-EA7215F5-654D-4F3B-B547-181FFFECA1DCQ90990039-BECF7D84-A3DA-45E3-B85B-903381805AE0Q91104064-1C6EB380-C0BC-4886-A3CC-E7E9B5DC2B7AQ91565377-DA1D418A-F942-4A85-8C13-FBDDF75DA682Q92184218-1FAC6487-AF55-43D4-9279-C417808DD435
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Petter Bjornstad
@ast
Petter Bjornstad
@en
Petter Bjornstad
@es
Petter Bjornstad
@nl
Petter Bjornstad
@sl
type
label
Petter Bjornstad
@ast
Petter Bjornstad
@en
Petter Bjornstad
@es
Petter Bjornstad
@nl
Petter Bjornstad
@sl
prefLabel
Petter Bjornstad
@ast
Petter Bjornstad
@en
Petter Bjornstad
@es
Petter Bjornstad
@nl
Petter Bjornstad
@sl
P106
P31
P496
0000-0002-5160-2947